Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

Researchers showed that approximately 80 percent of stage 3 melanoma patients who had detectable levels of circulating tumor ...

DNA fragments found in the bloodstream during treatment could mean that a patient’s cancer is getting worse, researchers said ...

CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Liquid biopsies offer a simpler way to detect cancer. Unlike traditional biopsies, it uses a blood draw. It helps monitor ...

Key Players to WatchDublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.